BioPharma Resources

Drugs by condition

Drugs approved for erectile dysfunction

Brand-name prescription drugs and biologics whose FDA label lists erectile dysfunction as an approved use. Matched on the label phrases: "erectile dysfunction".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

6

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

2

New molecular entities and new biologics

In development

12

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for erectile dysfunction.

  • Vybrique (Sildenafil Citrate) · Ibsa Dec 16, 2025
  • Cialis (Tadalafil) · Lilly NovelOrphanNov 21, 2003
  • Caverject Impulse (Alprostadil) · Pfizer Jun 11, 2002
  • Viagra (Sildenafil Citrate) · Viatris NovelPriority reviewMar 27, 1998
  • Edex (Alprostadil) · Endo Operations Jun 12, 1997

All approved drugs for erectile dysfunction, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 44 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Prostaglandin Analog (3)

Phosphodiesterase 5 Inhibitor (1)

  • Cialis Tadalafil · Lilly · 2003

Class not listed in FDA's data (2)

  • Viagra Sildenafil Citrate · Viatris · 1998
  • Vybrique Sildenafil Citrate · Ibsa · 2025

Drugs in development for erectile dysfunction

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • TestofenPhase 32 trials

    RDC Clinical Pty Ltd · Long Covid19, Erectile Dysfunction

  • DTT106Phase 31 trial

    EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction

  • HGP1201Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HIP2602Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HPP2602-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HPP2602-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • TPN171HSimmerafilPhase 31 trial

    Vigonvita Life Sciences · Erectile Dysfunction

  • W2505Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-P1Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-P2Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-RPhase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • LIB-01Phase 21 trial

    Dicot AB · Erectile Dysfunction

More on erectile dysfunction: recruiting trials · published research

Related in kidney and urology: Chronic kidney disease · IgA nephropathy · Overactive bladder · Enlarged prostate (BPH)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.